Sandoz Group

Profil de la société

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Description disponible en anglais.

Informations sur la société

Secteur

Santé

Industrie

Drug Manufacturers - Specialty & Generic

Pays

Suisse

Siège

Centralbahnstrasse 4, 4051, Basel

Salariés

20 000

Cotation

SDZ · SIX

Indices

SMI

Devise

CHF

ISIN

CH1243598427

Site web

sandoz.com